Search

Your search keyword '"Collonge-Rame, Marie-Agnes"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Collonge-Rame, Marie-Agnes" Remove constraint Author: "Collonge-Rame, Marie-Agnes"
33 results on '"Collonge-Rame, Marie-Agnes"'

Search Results

3. Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease

4. The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique

5. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11

6. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

7. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

8. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

10. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

11. Abnormalities of the long arm of chromosome 21 in 107 patients with hematopoietic disorders: a collaborative retrospective study of the Groupe Français de Cytogénétique Hématologique

13. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

14. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

15. Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

16. Identical abnormality of the short arm of chromosome 18 in two Philadelphia-positive chronic myelocytic leukemia patients with erythroblastic transformation, resulting in duplication of BCR-ABL1 fusion

17. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma

18. NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

19. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

20. Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers

21. Exploring the link between MORF4L1 and risk of breast cancer

22. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

23. Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

24. Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

25. Chromosomal abnormalities in transformed Ph‐negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations

26. Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.

27. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.

28. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

29. G-CSF–induced aneuploidy does not affect CD34+ cells and does not require cell division

30. Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYCand TP53Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique(GFCH) and the French Innovative Leukemia Organization(FILO) Group

31. Specific Chromosomal IGTranslocations Have Different Prognosis In Chronic Lymphocytic Leukemia

32. Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2and the TET2Statuses.

33. Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.

Catalog

Books, media, physical & digital resources